Navigating Economic Resilience Through Life Sci...

By João L. Carapinha

January 20, 2026

Navigating a Leaderless Global Economy Through Life Sciences Investment In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global...
Guiding Principles for Ethical AI Integration in Drug Development
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Driving Economic Transformation through Brain Health Investment in Africa
Novartis Drug Pricing Agreement
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...